The Animal Healthcare Market will witness a CAGR of 4.2% by reaching US$ 36.1 Bn from 2021-2031. The new-fangled healthcare electronic technologies like 3D printing, GPS tracking, and wearable biometric devices are being tested concerning clinical use. Cutting-edge technology is expected to be one of the driving forces in the healthcare industry in the subsequent decade.
Animal healthcare is known to have become an emphasis area for numerous drug companies, of late. This specific market has become considerably more significant due to increasing instances of animal disease occurrence, combined with large-scale factory farming that needs excellent quality animal feed additives, hygiene management products, as well as vaccines.
Major factor boosting demand for animal healthcare is industrialization of the dairy and meat industry across the world. Moreover, rising zoonotic and foodborne diseases and increasing trend of pet adoption are additionally complementing market expansion.
According to a revised report published by Persistence Market Research, the global animal healthcare market was valued at US$ 36.1 Bn in 2020, and is predicted to expand at a CAGR of more than 4% over the forecast period (2021-2031).
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2882
Company profiles:
- Bayer AG
- BoehringerIngelheim GmbH
- Virbac SA
- Zoetis, Inc.
- Hester Biosciences Ltd.
- Intas Pharmaceuticals Ltd.
- Merck Animal Health
- Elanco (Eli Lilly and Company)
- Ceva Santé Animale
- Alivira Animal Health Limited
- Vetoquinol S.A.
- Zydus Animal Health
- Norbrook Laboratories Limited
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC Norbrook Laboratories, Inc
Request for Methodology @ https://www.persistencemarketresearch.com/methodology/2882
Key Takeaways from Market Study
- Parasiticides are expected to contribute around 27% revenue share in the market by 2031, owing to increasing preference for animal care and hygiene.
- Farm animals are expected to account for more than half of the global market share. Industrialization of the dairy and meat industry has led to increasing demand for animal-based products, adding to the market development.
- Oral route of administration in animal healthcare is expected to contribute around 45% revenue share in the market by 2031, as it gives the highest level of drug stability and accurate measurements.
- Among all the distribution channels, veterinary hospitals accounted for more than 35% of the market share in 2020. Different applications such as clinical toxicology tests, therapy, and clinical pathology will boost market expansion.
- North America holds the highest share in the global market for animal healthcare, owing to the presence of big market players, high healthcare expenditure, and growing research & development efforts in the country.
- Key players are focused on strengthening their clinical pipelines with discoveries of novel abuse-deterrent formulations and also through various acquisitions.
- The market in the U.S. holds a big portion of global revenue at 30%, and accounts for more than 85% share in the North American market.
“Increase in incidence of infectious disease transmission in animals, growth in animal inhabitants, and rising adoption of companion animals are factors driving market growth,” says an analyst at Persistence Market Research.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/2882
Increased Funding & Support from International Organizations
International agencies such as U.K. Science have made major contributions toward global eradication of rinderpest diseases, and this has a major impact on controlling FMD and Peste des Petits in ruminants.
Other funding programs are often supported by the WHO, country-specific governments, and private humanitarian agencies. Stakeholders identify the need to prevent economic losses arising due to lack of effective vaccinations and instead take a proactive preventive dimension for animal healthcare.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the animal healthcare market in its latest study, presenting a historical demand assessment of 2016 – 2020 and projections for 2021 – 2031. The research study is based on drug (anti-infective agents, anti-inflammatory & analgesic agents, parasiticides, vaccines, hormones & substitutes, nutritional products, and others), animal (companion animals and farm animals), route of administration (oral, parenteral, topical, and others) and distribution channel (veterinary hospital, veterinary clinics, pharmacies and drug stores, and others), across seven key regions of the world.
Access Related Reports:
Computerized Physician Order Entry Systems Market:
The global computerized physician order entry systems market is valued at USD 999.4 million in 2014 and is expected to grow at a CAGR of 6.8% from 2014 to 2020, to reach an estimated value of USD 1,481.7 million in 2020.
Emergency Contraceptive Pills Market:
By the end of 2022, the global market for emergency contraceptive pills will have reached a value of just over US$ 1,230 Mn. During the forecast period, 2017-2022, the global emergency contraceptive pill market is anticipated to exhibit sluggish growth and reflect less than 3% CAGR.
Insomnia Treatment Market:
Multiple companies in the market are working on wearable devices for insomnia treatment, one of which is smart goggles; patients can now be wearing a pair of smart goggles to sleep off.
Acupuncture Market:
Currently, acupuncture services are provided at 73% of National Cancer Institute (NCI), Comprehensive Cancer Centres in the U.S., and more than 1,300 physician acupuncturists are present in North America. Persistence Market Research predicts that the global acupuncture market would exhibit 16% CAGR during the forecast period (2019-2029).
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com